Randomized Phase II Study Comparing Dose Escalated Weekly Paclitaxel versus Standard Dose Weekly Paclitaxel for Patients with Previously Treated Advanced Gastric Cancer
Phase 2
- Conditions
- Previously Treated Advanced or Recurrent Gastric Cancer
- Registration Number
- JPRN-UMIN000004055
- Lead Sponsor
- Aichi Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
1. Alcohol intolerance 2. Symptomatic brain metastasis 3. Paralytic or mechanical bowel obstruction 4. Watery diarrhea 5. Uncontrolled ascites or pleural effusions 6. Confirmed or suspected infection 7. Severe pulmonary disease (interstitial pneumonia, pulmonary fibrosis, severe emphysematous) 8. Severe comorbidities (uncontrollable diabetes, heart failure with NYHA III or IV, renal failure, liver failure) 9. Pregnant woman, lactating woman 10. Sever neurologic disease 11. Grade2 or more neuropathy 12. HIV infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method